» Authors » Piyush Pathak

Piyush Pathak

Explore the profile of Piyush Pathak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 130
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pathak P, Thomas J, Baghwala A, Li C, Teh B, Butler E, et al.
Cancers (Basel) . 2024 Oct; 16(19). PMID: 39410041
Brachytherapy offers a highly conformal and adaptive approach to radiation therapy for various oncologic conditions. This review explores the rationale, applications, technological advances, and future directions of personalized brachytherapy. Integration...
2.
Vaishnav M, Biswas S, Shenoy A, Pathak P, Anand A, Swaroop S, et al.
Aliment Pharmacol Ther . 2024 Jan; 59(5):645-655. PMID: 38186012
Background: In cirrhosis patients with acute variceal bleeding (AVB), the optimal duration of vasoconstrictor therapy after endoscopic haemostasis is unclear. Aims: We aimed to compare efficacy of 1-day versus 3-day...
3.
Arora U, Goyal R, Teh K, Pei Y, Goh G, Lin S, et al.
Dig Dis Sci . 2023 Sep; 68(12):4485-4498. PMID: 37733130
Background: Non-invasive tests (NITs) are useful to assess advanced fibrosis (AF) in nonalcoholic fatty liver disease (NAFLD). Data from Asian countries suggest that these tests have poor performance. We aimed...
4.
Vaishnav M, Biswas S, Anand A, Pathak P, Swaroop S, Aggarwal A, et al.
Diagnostics (Basel) . 2023 Jul; 13(14). PMID: 37510129
Background: The role of hepatic venous pressure gradient (HVPG) in predicting further decompensation in cirrhosis patients with acute variceal bleeding (AVB) is not known. We aimed to evaluate the role...
5.
Biswas S, Vaishnav M, Farooqui N, Aggarwal A, Pathak P, Yadav R, et al.
Postgrad Med J . 2023 Jun; 99(1176):1094-1103. PMID: 37308443
Background: The relationship between body mass index (BMI) and outcomes in patients with nonalcoholic fatty liver disease (NAFLD) is not well defined. This study aimed to assess the presentations, outcomes,...
6.
Acharya P, Saha R, Quadri J, Sarwar S, Ahmad Khan M, Sati H, et al.
Front Immunol . 2023 Feb; 13:1041230. PMID: 36776389
Background: Acute kidney injury (AKI) considerably increases the risk of short-term mortality in acute-on-chronic liver failure (ACLF) but predicting AKI is not possible with existing tools. Our study aimed at...
7.
Shalimar , Sheikh S, Biswas S, Vaishnav M, Pathak P, Pachisia A, et al.
J Clin Exp Hepatol . 2023 Jan; 13(1):37-47. PMID: 36647411
Background: Nonalcoholic fatty liver disease (NAFLD) is the commonest type of liver disease worldwide. We aimed to assess the incidence and predictors of liver-related events (LREs) and mortality in NAFLD...
8.
Swaroop S, Arora U, Biswas S, Vaishnav M, Pathak P, Agarwal A, et al.
J Clin Apher . 2022 Nov; 38(4):376-389. PMID: 36408827
Background: Acute-on-chronic liver failure (ACLF) is associated with a high short-term mortality rate in the absence of liver transplantation. The role of therapeutic plasma exchange (TPE) in improving the outcomes...
9.
Goel A, Verma A, Tiwari P, Katiyar H, Aggarwal A, Khetan D, et al.
Vaccines (Basel) . 2022 Nov; 10(11). PMID: 36366346
Introduction: Data are limited on antibody response to the ChAdOx1 nCoV-19 vaccine (AZD1222; Covishield®) in cirrhosis. We studied the antibody response following two doses of the ChAdOx1 vaccine, given 4−12...
10.
Aggarwal P, Seenivasagam R, Sood A, Prashar S, Pathak P, Sachdeva N, et al.
J Nucl Med Technol . 2022 Nov; 51(1):68-69. PMID: 36351798
Besides the known physiologic uptake of I, the literature describes various false-positive findings on I scans in benign lesions, inflammation, traumatic sites, and postsurgical sites, to name a few. However,...